AMIM
ABBV icon

Aull & Monroe Investment Management’s AbbVie ABBV Stock Holding History

Aull & Monroe Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.65M Sell
14,519
-59
-0.4% -$12.7K 1.53% 20
2026
Q1 		$3.17M Sell
14,578
-48
-0.3% -$10.6K 1.47% 21
2025
Q4 		$3.34M Sell
14,626
-6
-0% -$1.37K 1.67% 19
2025
Q3 		$3.39M Sell
14,632
-413
-3% -$84.1K 1.73% 19
2025
Q2 		$2.79M Sell
15,045
-3,445
-19% -$640K 1.5% 22
2025
Q1 		$3.87M Hold
18,490
– – 1.93% 18
2024
Q4 		$3.29M Sell
18,490
-1,130
-6% -$208K 1.68% 20
2024
Q3 		$3.87M Sell
19,620
-33
-0.2% -$6.16K 1.8% 17
2024
Q2 		$3.37M Sell
19,653
-2,282
-10% -$378K 1.65% 20
2024
Q1 		$3.99M Sell
21,935
-435
-2% -$75K 1.83% 16
2023
Q4 		$3.47M Sell
22,370
-370
-2% -$53.9K 1.71% 19
2023
Q3 		$3.39M Sell
22,740
-200
-0.9% -$29.4K 1.77% 19
2023
Q2 		$3.09M Hold
22,940
– – 1.56% 19
2023
Q1 		$3.66M Buy
22,940
+84
+0.4% +$12.8K 1.86% 17
2022
Q4 		$3.69M Sell
22,856
-614
-3% -$94.1K 1.84% 16
2022
Q3 		$3.15M Hold
23,470
– – 1.73% 19
2022
Q2 		$3.59M Hold
23,470
– – 1.82% 18
2022
Q1 		$3.81M Sell
23,470
-25
-0.1% -$3.63K 1.72% 18
2021
Q4 		$3.18M Sell
23,495
-214
-0.9% -$25.3K 1.42% 23
2021
Q3 		$2.56M Buy
23,709
+50
+0.2% +$5.71K 1.26% 29
2021
Q2 		$2.67M Hold
23,659
– – 1.27% 29
2021
Q1 		$2.56M Buy
23,659
+496
+2% +$53.1K 1.25% 28
2020
Q4 		$2.48M Sell
23,163
-121
-0.5% -$11.6K 1.32% 28
2020
Q3 		$2.04M Buy
23,284
+1,400
+6% +$132K 1.2% 27
2020
Q2 		$2.15M Sell
21,884
-1,925
-8% -$169K 1.33% 23
2020
Q1 		$1.81M Sell
23,809
-75
-0.3% -$6.39K 1.22% 26
2019
Q4 		$2.12M Sell
23,884
-550
-2% -$45.7K 1.07% 32
2019
Q3 		$1.85M Sell
24,434
-1,190
-5% -$81.6K 0.98% 37
2019
Q2 		$1.86M Sell
25,624
-300
-1% -$23.6K 0.99% 37
2019
Q1 		$2.09M Sell
25,924
-1,050
-4% -$85.9K 1.12% 30
2018
Q4 		$2.49M Sell
26,974
-1,350
-5% -$119K 1.42% 22
2018
Q3 		$2.68M Sell
28,324
-400
-1% -$37.9K 1.29% 26
2018
Q2 		$2.66M Sell
28,724
-300
-1% -$29.3K 1.37% 21
2018
Q1 		$2.75M Sell
29,024
-100
-0.3% -$11K 1.43% 21
2017
Q4 		$2.82M Sell
29,124
-680
-2% -$64.1K 1.42% 21
2017
Q3 		$2.65M Hold
29,804
– – 1.36% 22
2017
Q2 		$2.16M Sell
29,804
-200
-0.7% -$13.4K 1.15% 30
2017
Q1 		$1.96M Sell
30,004
-200
-0.7% -$12.6K 1.05% 33
2016
Q4 		$1.89M Sell
30,204
-200
-0.7% -$12.2K 1.06% 32
2016
Q3 		$1.92M Hold
30,404
– – 1.1% 31
2016
Q2 		$1.88M Sell
30,404
-386
-1% -$23.5K 1.08% 31
2016
Q1 		$1.76M Sell
30,790
-900
-3% -$50.2K 1.05% 32
2015
Q4 		$1.88M Sell
31,690
-400
-1% -$23K 1.16% 30
2015
Q3 		$1.75M Sell
32,090
-337
-1% -$21.9K 1.13% 31
2015
Q2 		$2.25M Sell
32,427
-2,007
-6% -$131K 1.32% 29
2015
Q1 		$2.02M Sell
34,434
-300
-0.9% -$18.1K 1.13% 32
2014
Q4 		$2.27M Sell
34,734
-3,483
-9% -$220K 1.24% 30
2014
Q3 		$2.21M Buy
38,217
+298
+0.8% +$16.5K 1.17% 32
2014
Q2 		$2.14M Buy
37,919
+700
+2% +$36.7K 1.14% 32
2014
Q1 		$1.91M Sell
37,219
-600
-2% -$30.3K 1.09% 33
2013
Q4 		$2M Buy
37,819
+13,004
+52% +$639K 1.17% 32
2013
Q3 		$1.11M Sell
24,815
-13,054
-34% -$579K 0.72% 50
2013
Q2 		$1.57M Buy
+37,869
New +$1.66M 1.05% 37

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Aull & Monroe Investment Management's ABBV Position: Q2 2026 in Review

Aull & Monroe Investment Management reduced its AbbVie (ABBV) stake by 0.4% in Q2 2026, selling an estimated $12.7K and leaving 14,519 shares worth $3.65M. The position accounts for 1.53% of the portfolio, ranked #20.

Aull & Monroe Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.99M in Q1 2024. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Aull & Monroe Investment Management held 14,519 shares of AbbVie worth $3.65M as of Q2 2026.
  • Aull & Monroe Investment Management sold 59 AbbVie shares in Q2 2026, an estimated $12.7K.
  • AbbVie made up 1.53% of Aull & Monroe Investment Management's portfolio in Q2 2026, its #20 holding.
  • Aull & Monroe Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Aull & Monroe Investment Management's AbbVie position peaked at $3.99M in Q1 2024.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aull & Monroe Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.